GENFIT
Develops therapies and diagnostics for patients with rare and severe liver diseases.
GNFT | PA
Overview
Corporate Details
- ISIN(s):
- FR0004163111 (+2 more)
- LEI:
- 969500XPWN2DMZQA5X73
- Country:
- France
- Address:
- 885 AVENUE EUGENE AVINEE, 59120 LOOS
- Website:
- https://www.genfit.com
Description
GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-05-10 08:05 |
GENFIT : Assemblée générale ordinaire du 13 juin 2019 – modalités de mise à dis…
|
French | 162.6 KB | ||
| 2019-04-30 07:30 |
GENFIT: GENFIT : Information financière du premier trimestre 2019
|
French | 177.6 KB | ||
| 2019-04-30 07:30 |
Genfit: GENFIT: Reports First quarter 2019 Financial Information
|
English | 184.5 KB | ||
| 2019-04-18 07:00 |
Genfit : GENFIT annonce l’attribution de la Breakthrough Therapy Designation à …
|
French | 154.6 KB | ||
| 2019-04-18 07:00 |
Genfit: GENFIT Announces FDA Grant of Breakthrough Therapy Designation to Elafi…
|
English | 160.5 KB | ||
| 2019-04-13 08:23 |
Genfit : GENFIT présentera de nouvelles données issues de l’essai clinique posi…
|
French | 325.3 KB | ||
| 2019-04-13 08:23 |
Genfit: GENFIT to Present Additional Data from the Positive Phase 2 Clinical Tr…
|
English | 315.3 KB | ||
| 2019-04-04 08:33 |
Genfit: GENFIT annonce la présentation de nouvelles données sur ses programmes …
|
French | 203.8 KB | ||
| 2019-04-04 08:33 |
Genfit: GENFIT Announces Upcoming Presentations on NASH, PBC and Diagnostics at…
|
English | 265.4 KB | ||
| 2019-04-03 10:21 |
Franchissement de seuils
|
French | 196.0 KB | ||
| 2019-03-29 18:10 |
Genfit : GENFIT annonce le règlement-livraison de l’Offre Globale
|
French | 268.5 KB | ||
| 2019-03-29 18:10 |
Genfit: GENFIT Announces Closing of Global Offering and Full Exercise of Underw…
|
English | 160.4 KB | ||
| 2019-03-28 21:57 |
Genfit : GENFIT annonce l’exercice intégral de l’option de surallocation dans l…
|
French | 278.6 KB | ||
| 2019-03-28 21:57 |
Genfit: GENFIT Announces the Exercise in Full of the Option Granted to the Unde…
|
English | 342.6 KB | ||
| 2019-03-27 18:12 |
Genfit: MISE À DISPOSITION DU PROSPECTUS AYANT RECU LE VISA NO. 19-118 DE L’AUT…
|
French | 277.4 KB |
Automate Your Workflow. Get a real-time feed of all GENFIT filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GENFIT
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GENFIT via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-07-07 | N/A | Other | Buy | 5,300 | 19,488.10 EUR |
| 2023-07-06 | N/A | Other | Buy | 1,100 | 4,048.00 EUR |
| 2023-07-05 | N/A | Other | Buy | 10,000 | 37,061.00 EUR |
| 2023-07-03 | N/A | Other | Buy | 5,300 | 18,769.95 EUR |
Peer Companies
